Evidence map›Paper›PMID 29263157›Full record

ArticleMolecular and cellular biology2018

SRC Increases

Christopher Abdullah, Hasan Korkaya, Shinji Iizuka, Sara A Courtneidge

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and cellular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Christopher AbdullahBiomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California, USA.
Hasan KorkayaDepartment of Biochemistry and Molecular Biology, Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
Shinji IizukaDepartment of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, Oregon, USA.
Sara A CourtneidgeDepartment of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, Oregon, USA courtneidge@ohsu.edu.
Oregon Health & Science University · USAugusta University Health · USUniversity of California, San Diego · US

Funding

Src, p53 and estrogen receptor-positive breast cancerR21CA177382 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI COURTNEIDGE, SARA A · 2014 to 2015
$368k
The role of Src kinase in estrogen receptor-positive breast cancer proliferationF31CA180740 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ABDULLAH, CHRISTOPHER · 2013 to 2017
$137k
NCI NIH HHS F31 CA180740NCI NIH HHS R21 CA177382
6 · The paper itself

Abstract

The transcription factor gene

Indexed as

AnimalsBreast NeoplasmsCell CycleCell Line, TumorCell ProliferationEstradiolFemaleGene Expression Regulation, NeoplasticHEK293 CellsHeterograftsHumansMCF-7 CellsMice, NudeProto-Oncogene Proteins c-mycReceptors, EstrogenRNA-Binding ProteinsEstradiolIGF2BP1 protein, humanMYC protein, humanProto-Oncogene Proteins c-mycReceptors, EstrogenRNA-Binding ProteinsRNA, Messengersrc-Family KinasesTP53 protein, humanTumor Suppressor Protein p53breast cancerc-mycestrogenp53SRC

Identifiers

PMID29263157
PMCPMC5829483
OpenAlexW2791468623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.